DE69334087D1 - Arzneimittelzusammensetzung enthaltend TCF-II - Google Patents

Arzneimittelzusammensetzung enthaltend TCF-II

Info

Publication number: DE69334087D1
Authority: DE; Germany
Prior art keywords: composition containing; drug composition; tcf; containing tcf; derived
Prior art date: 1992-07-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69334087T

Other languages

English (en)

Other versions

DE69334087T2 (de

Inventor

Hiroaki Masunaga

Nobuaki Fujise

Kanji Higashi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Atlas Pharmaceuticals Inc Sunnyvale Calif Us

Original Assignee

Daiichi Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-16

Filing date

1993-07-16

Publication date

2007-01-04

1992-07-16 Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja

1992-07-16 Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja

1992-08-10 Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja

1993-07-16 Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd

2007-01-04 Application granted granted Critical

2007-01-04 Publication of DE69334087D1 publication Critical patent/DE69334087D1/de

2007-07-05 Publication of DE69334087T2 publication Critical patent/DE69334087T2/de

2013-07-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Surgery (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE69334087T 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend TCF-II Expired - Fee Related DE69334087T2 (de)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
JP21222792A JP3619526B2 (ja)	1992-07-16	1992-07-16	Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP21222992		1992-07-16
JP21222792		1992-07-16
JP21222992A JP3380573B2 (ja)	1992-07-16	1992-07-16	Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP4234198A JPH0656692A (ja)	1992-08-10	1992-08-10	Ｔｃｆ−ｉｉを有効成分とする創傷治療剤
JP23419892		1992-08-10

Publications (2)

Publication Number	Publication Date
DE69334087D1 true DE69334087D1 (de)	2007-01-04
DE69334087T2 DE69334087T2 (de)	2007-07-05

Family

ID=27329338

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DE69314586T Expired - Fee Related DE69314586T2 (de)	1992-07-16	1993-07-16	Arzneimittelzusammensetzung enthaltend TCF-II
DE69334281T Expired - Fee Related DE69334281D1 (de)	1992-07-16	1993-07-16	TCF-II enthaltende medizinische Zusammensetzung
DE69334087T Expired - Fee Related DE69334087T2 (de)	1992-07-16	1993-07-16	Arzneimittelzusammensetzung enthaltend TCF-II

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DE69314586T Expired - Fee Related DE69314586T2 (de)	1992-07-16	1993-07-16	Arzneimittelzusammensetzung enthaltend TCF-II
DE69334281T Expired - Fee Related DE69334281D1 (de)	1992-07-16	1993-07-16	TCF-II enthaltende medizinische Zusammensetzung

Country Status (7)

Country	Link
EP (3)	EP1719522B1 (de)
KR (1)	KR100271087B1 (de)
AT (3)	ATE345809T1 (de)
CA (1)	CA2100720C (de)
DE (3)	DE69314586T2 (de)
DK (2)	DK0588477T3 (de)
ES (2)	ES2110057T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3634359B2 (ja) *	1992-07-16	2005-03-30	第一製薬株式会社	Ｔｃｆ−▲ｉｉ▼を有効成分とする血液凝固正常化剤
JP3402476B2 (ja) *	1992-08-24	2003-05-06	生化学工業株式会社	リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) *	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
NZ298141A (en) *	1994-12-27	2000-12-22	Snow Brand Milk Products Co Ltd	Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) *	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
CA2253629A1 (en)	1997-03-14	1998-09-24	Snow Brand Milk Products Co., Ltd.	Agent for preventing and/or treating cachexia
JP3961064B2 (ja) *	1997-03-28	2007-08-15	第一製薬株式会社	腎疾患予防及び／又は治療剤
JPH1129493A (ja) *	1997-07-14	1999-02-02	Snow Brand Milk Prod Co Ltd	放射線障害予防及び／又は治療剤
JPH11269091A (ja) *	1998-03-19	1999-10-05	Snow Brand Milk Prod Co Ltd	敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3904753A (en) *	1970-02-20	1975-09-09	Research Corp	Clinically active bovine growth hormone fraction
JPS58146293A (ja)	1982-02-26	1983-08-31	Mochida Pharmaceut Co Ltd	抗腫瘍性糖蛋白質の製造方法
US4708948A (en)	1984-04-20	1987-11-24	The United States Of America As Represented By The Department Of Health And Human Services	Substantially purified tumor growth inhibitory factor
DE3419184A1 (de)	1984-05-23	1985-11-28	Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart	Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja)	1985-10-28	1987-05-13	Yoshitomi Pharmaceut Ind Ltd	細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) *	1986-07-14	1996-12-18	修治橋本	肝細胞増殖因子
JPS6410998A (en)	1986-12-22	1989-01-13	Green Cross Corp	Tumor cell inhibitory factor
NZ232813A (en)	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) *	1989-09-07	1991-07-30	Institute Of Moelcular Biology, Inc.	Wound healing composition of IL-1 and PDGF or IGF-1
EP0859009B1 (de) *	1990-06-11	2005-11-30	Toshikazu Nakamura	Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
WO1992001053A1 (fr)	1990-07-13	1992-01-23	Snow Brand Milk Products Co., Ltd.	Plasmide contenant l'adn qui code pour la sequence d'acides amines du facteur tcf-ii, cellules transformees par ce plasmide et production d'une substance physiologiquement active grace a l'utilisation de ce plasmide

1993
- 1993-07-16 CA CA002100720A patent/CA2100720C/en not_active Expired - Fee Related
- 1993-07-16 EP EP06076444A patent/EP1719522B1/de not_active Expired - Lifetime
- 1993-07-16 DK DK93305602.0T patent/DK0588477T3/da active
- 1993-07-16 ES ES93305602T patent/ES2110057T3/es not_active Expired - Lifetime
- 1993-07-16 ES ES97100939T patent/ES2276409T3/es not_active Expired - Lifetime
- 1993-07-16 DE DE69314586T patent/DE69314586T2/de not_active Expired - Fee Related
- 1993-07-16 KR KR1019930013391A patent/KR100271087B1/ko not_active IP Right Cessation
- 1993-07-16 DE DE69334281T patent/DE69334281D1/de not_active Expired - Fee Related
- 1993-07-16 AT AT97100939T patent/ATE345809T1/de not_active IP Right Cessation
- 1993-07-16 AT AT06076444T patent/ATE428438T1/de not_active IP Right Cessation
- 1993-07-16 EP EP93305602A patent/EP0588477B1/de not_active Expired - Lifetime
- 1993-07-16 DK DK97100939T patent/DK0821969T3/da active
- 1993-07-16 DE DE69334087T patent/DE69334087T2/de not_active Expired - Fee Related
- 1993-07-16 EP EP97100939A patent/EP0821969B1/de not_active Expired - Lifetime
- 1993-07-16 AT AT93305602T patent/ATE159171T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1719522B1 (de)	2009-04-15
DK0821969T3 (da)	2007-03-26
ES2276409T3 (es)	2007-06-16
ATE159171T1 (de)	1997-11-15
DE69334087T2 (de)	2007-07-05
DE69334281D1 (de)	2009-05-28
ATE428438T1 (de)	2009-05-15
EP0821969A2 (de)	1998-02-04
CA2100720C (en)	2003-03-11
ATE345809T1 (de)	2006-12-15
CA2100720A1 (en)	1994-01-17
EP0588477A3 (en)	1994-05-25
AU673835B2 (en)	1996-11-28
KR100271087B1 (en)	2000-11-01
EP0821969B1 (de)	2006-11-22
AU4194593A (en)	1994-01-20
DE69314586D1 (de)	1997-11-20
ES2110057T3 (es)	1998-02-01
DK0588477T3 (da)	1998-03-30
EP0588477A2 (de)	1994-03-23
EP0821969A3 (de)	2000-12-13
EP0588477B1 (de)	1997-10-15
EP1719522A1 (de)	2006-11-08
DE69314586T2 (de)	1998-02-19
KR940005286A (ko)	1994-03-21

Publication	Publication Date	Title
NO910340D0 (no)	1991-01-29	Topiske preparater for behandling av menneskenegler.
MX9801596A (es)	1998-08-30	Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
ATE197670T1 (de)	2000-12-15	Parenterales busulfan zur behandlung von malignen krankheiten
NO20004282D0 (no)	2000-08-25	Matriksproteinpreparater for sÕrheling
ATE243196T1 (de)	2003-07-15	Piperidine und pyrrolidine
MX9708800A (es)	1998-02-28	Compuestos biciclicos aromaticos.
DE68913739D1 (de)	1994-04-14	Kosmetische und hautbehandlungs-zusammensetzungen.
ATE200661T1 (de)	2001-05-15	Bisaromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und verwendungen
BR9813318A (pt)	2000-08-22	Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
MX9708803A (es)	1998-02-28	Compuestos biaromaticos de propinilo o dienilo.
DE69334087D1 (de)	2007-01-04	Arzneimittelzusammensetzung enthaltend TCF-II
DE69916488D1 (de)	2004-05-19	Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
IT1240683B (it)	1993-12-17	Composizione farmaceutica contenente egf
ATE151774T1 (de)	1997-05-15	Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
GR3032224T3 (en)	2000-04-27	Therapeutic agent for threatened abortion.
ATE5256T1 (de)	1983-11-15	Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
BG103905A (en)	2000-07-31	New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE68905076D1 (de)	1993-04-08	Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ATE106732T1 (de)	1994-06-15	Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
DE69719190D1 (de)	2003-03-27	Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
ATE206056T1 (de)	2001-10-15	Therapeutisches agens für neutropenie
KR930703003A (ko)	1993-11-29	피부질환치료용 제약 조성물
ZA979135B (en)	1998-06-24	New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
ATE59776T1 (de)	1991-01-15	Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date	Code	Title	Description
2007-12-13	8364	No opposition during term of opposition
2009-11-05	8327	Change in the person/name/address of the patent owner	Owner name: ATLAS PHARMACEUTICALS, INC., SUNNYVALE, CALIF., US
2011-05-19	8339	Ceased/non-payment of the annual fee